Statistics
Publications
25
Citations
4.6K
H-Index
23
Active since
2004
Vanessa Rodrik-Outmezguine is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, medicine, and molecular oncology.
Publications per year
2004–2024
25
25
Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS
Zhan Yao, Rona Yaeger, Vanessa Rodrik-Outmezguine et al. · Nature · 2017 · 562 citations
Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor
Vanessa Rodrik-Outmezguine, Masanori Okaniwa, Zhan Yao et al. · Nature · 2016 · 482 citations
1–5 of 25